Home/Pipeline/AGENT DCB

AGENT DCB

Coronary In-Stent Restenosis

FDA ApprovedPost-MarketNCT04647201

Key Facts

Indication
Coronary In-Stent Restenosis
Phase
FDA Approved
Status
Post-Market
Company

About Boston Scientific

Boston Scientific is a diversified medical device leader with a mission to advance science for life by delivering innovative, minimally invasive solutions. The company has achieved sustained growth through strategic diversification beyond its cardiovascular roots into high-growth areas like neuromodulation and endoscopy, supported by a robust R&D engine and strategic acquisitions. Its strategy focuses on addressing unmet clinical needs with category-leading technologies, driving global expansion, and improving patient outcomes while delivering shareholder value.

View full company profile